+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

S

Actively Recruiting

This research aims to study the epidemiology of invasive bacterial diseases caused by Streptococcus pneumoniae pneumococcus, Neisseria meningitidis meningococcus, and Haemophilus influenzae hemophilus. These infections can cause severe illness and serious complications. The study focuses on monitoring these infections to guide public health efforts, evaluate vaccine impacts, and plan prevention and treatment strategies by identifying circulating strains and assessing vaccine failures. The study uses molecular diagnostic testing to identify these bacteria from blood samples, even when traditional culture methods may fail due to prior antibiotic use or sample handling issues. Pediatric and adult patients diagnosed with invasive bacterial diseases caused by these pathogens are included. This approach enables more accurate detection and characterization of the bacteria. Participants diagnosed with these invasive bacterial infections will have their samples analyzed using molecular methods. Researchers will monitor the incidence rates of these infections in children, the distribution of bacterial types, and the proportion of cases preventable by vaccination. The study will also assess vaccine failure rates. The average study duration for outcome measurement is about one year, supporting improved surveillance and public health interventions.

Age: 1Day - 70YearsAll Genders
38 locations
E

Actively Recruiting

The trial investigates whether transcatheter aortic valve implantation TAVI can be safely and effectively performed in hospitals without on-site cardiac surgery for patients with severe symptomatic aortic stenosis. This multicenter, randomized study compares outcomes between centers with and without on-site cardiac surgery to determine if patient safety is maintained when appropriate selection, experienced operators, advanced imaging, and transfer plans are in place. The goal is to improve access to timely treatment while ensuring clinical safety at 1 year. Participants will be randomly assigned to receive TAVI either in a center without on-site cardiac surgery or in a center with on-site cardiac surgery. Both groups undergo the procedure performed by experienced operators following current guidelines and standards. Centers without on-site surgery must have advanced imaging, procedural expertise, and established transfer pathways. Patients will be evaluated beforehand with clinical, echocardiographic, laboratory, coronary, and computed tomography assessments to confirm eligibility and procedural feasibility. During the study, participants will be monitored for clinical outcomes including death from any cause, stroke, and hospitalizations related to the procedure or implanted valve at 1 year. Safety events such as valve-related death and major complications will also be recorded. Clinical events will be reviewed by an independent committee blinded to treatment assignment, and patient safety will be overseen by a data monitoring board. After hospital discharge, participants will have structured follow-up visits to assess health status, adverse events, and hospitalizations, with total participation lasting up to 1 year.

All AgesAll GendersPhase Not Applicable
11 locations